tiprankstipranks
Trending News
More News >
WOLVES HAND Co.,Ltd. (JP:194A)
:194A
Japanese Market

WOLVES HAND Co.,Ltd. (194A) AI Stock Analysis

Compare
0 Followers

Top Page

JP:194A

WOLVES HAND Co.,Ltd.

(194A)

Select Model
Select Model
Select Model
Outperform 75 (OpenAI - 5.2)
,
Outperform 75 (OpenAI - 5.2)
,
Outperform 75 (OpenAI - 5.2)
,
Outperform 75 (OpenAI - 5.2)
,
Outperform 75 (OpenAI - 5.2)
,
Outperform 75 (OpenAI - 5.2)
,
Outperform 75 (OpenAI - 5.2)
,
Outperform 75 (OpenAI - 5.2)
,
Outperform 75 (OpenAI - 5.2)
,
Outperform 75 (OpenAI - 5.2)
,
Outperform 75 (OpenAI - 5.2)
,
Outperform 75 (OpenAI - 5.2)
,
Outperform 75 (OpenAI - 5.2)
,
Outperform 75 (OpenAI - 5.2)
,
Outperform 75 (OpenAI - 5.2)
Rating:75Outperform
Price Target:
¥1,888.00
▲(1.67% Upside)
Action:ReiteratedDate:11/28/25
WOLVES HAND Co.,Ltd. demonstrates strong financial performance with consistent revenue growth and solid cash flow management, contributing significantly to the overall score. The technical analysis supports a bullish outlook with the stock trading above key moving averages. However, the high P/E ratio suggests potential overvaluation, which slightly tempers the overall score.
Positive Factors
Free Cash Flow Strength
A free cash flow to net income ratio of 88.29% signals sustainable cash conversion from operations. Durable FCF supports debt reduction, capital expenditures, and selective reinvestment or M&A without relying on external financing, preserving financial flexibility over the next 2–6 months.
Improved Leverage
Reducing debt-to-equity from 3.14 to 0.93 materially lowers financial risk and interest burden. This stronger capital structure increases resilience to revenue volatility, enables strategic investments, and provides enduring capacity to fund operations or growth initiatives without destabilizing the balance sheet.
Healthy Profit Margins
Sustained gross and net margins indicate structural operational efficiency in its medical care facilities business. Strong margins support durable cash generation and provide a buffer against cost inflation, helping the company maintain profitability and fund reinvestment over the medium term.
Negative Factors
Declining Return on Equity
A drop in ROE from 33.29% to 21.84% signals weaker returns on shareholder capital. Over several months this could reflect margin compression, slower asset utilization, or capital base expansion without commensurate earnings, which may limit the company’s ability to deliver improving shareholder returns.
Modest Revenue Growth
Revenue growth of 3.65% is modest for a firm executing expansion or modernization in medical care facilities. Sustained low top-line growth can constrain scalability, limit operating leverage benefits, and slow improvements in absolute cash generation absent margin expansion or new service lines.
Limited Earnings Visibility
The absence of guidance and earnings-call highlights reduces forward visibility for investors and stakeholders. Over a multi-month horizon, limited disclosure can hinder planning, obscure near-term operational risks or investment needs, and weaken stakeholder confidence in management transparency.

WOLVES HAND Co.,Ltd. (194A) vs. iShares MSCI Japan ETF (EWJ)

WOLVES HAND Co.,Ltd. Business Overview & Revenue Model

Company DescriptionWOLVES HAND Co., Ltd. manages and operates animal hospitals in Japan. It also operates animals grooming salons and pet hotels, as well as provides seminars for veterinarians. The company was founded in 1999 and is based in Osaka, Japan.

WOLVES HAND Co.,Ltd. Financial Statement Overview

Summary
WOLVES HAND Co.,Ltd. exhibits a strong financial position with consistent revenue growth, solid profitability, and improved leverage. While the return on equity has decreased, the company has effectively managed its cash flows, resulting in a healthy financial outlook. The balance sheet improvements and strong cash flow generation position the company well for future growth and stability.
Income Statement
85
Very Positive
WOLVES HAND Co.,Ltd. has demonstrated consistent revenue growth over the years, with a 3.65% increase in the latest period. The company maintains healthy margins, with a gross profit margin of approximately 27% and a net profit margin of 10.85%. The EBIT and EBITDA margins are also strong, indicating efficient operations. Overall, the income statement reflects a stable and growing revenue base with solid profitability.
Balance Sheet
70
Positive
The company's debt-to-equity ratio has improved significantly from 3.14 to 0.93, indicating better leverage management. However, the return on equity has decreased from 33.29% to 21.84%, suggesting a decline in profitability relative to shareholder equity. The equity ratio stands at approximately 44.89%, reflecting a balanced capital structure. Overall, the balance sheet shows improved leverage but a slight decline in return on equity.
Cash Flow
75
Positive
WOLVES HAND Co.,Ltd. has shown strong free cash flow growth, with a significant increase in free cash flow in the latest period. The operating cash flow to net income ratio is 0.48, indicating efficient cash generation relative to net income. The free cash flow to net income ratio is high at 88.29%, reflecting robust cash flow management. Overall, the cash flow statement indicates strong cash generation and effective cash management.
BreakdownJun 2025Jun 2024Jun 2023Jun 2022
Income Statement
Total Revenue5.46B4.99B4.65B4.30B
Gross Profit1.32B1.23B1.14B1.08B
EBITDA1.22B1.15B1.12B1.03B
Net Income593.02M558.41M506.13M316.87M
Balance Sheet
Total Assets6.06B5.78B5.45B4.71B
Cash, Cash Equivalents and Short-Term Investments895.33M910.88M690.14M535.36M
Total Debt2.54B3.00B3.23B3.18B
Total Liabilities3.34B3.67B3.93B3.70B
Stockholders Equity2.72B2.11B1.52B1.01B
Cash Flow
Free Cash Flow837.42M414.75M518.82M-1.00B
Operating Cash Flow948.56M857.53M951.32M607.90M
Investing Cash Flow-388.74M-434.28M-644.29M-1.67B
Financing Cash Flow-575.37M-193.93M-160.82M617.34M

WOLVES HAND Co.,Ltd. Technical Analysis

Technical Analysis Sentiment
Negative
Last Price1857.00
Price Trends
50DMA
1917.96
Negative
100DMA
1869.48
Negative
200DMA
1380.99
Positive
Market Momentum
MACD
-59.88
Positive
RSI
39.21
Neutral
STOCH
17.80
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:194A, the sentiment is Negative. The current price of 1857 is above the 20-day moving average (MA) of 1800.55, below the 50-day MA of 1917.96, and above the 200-day MA of 1380.99, indicating a neutral trend. The MACD of -59.88 indicates Positive momentum. The RSI at 39.21 is Neutral, neither overbought nor oversold. The STOCH value of 17.80 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:194A.

WOLVES HAND Co.,Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
81
Outperform
¥2.91B4.692.82%4.82%9.78%
75
Outperform
¥12.54B25.86
75
Outperform
¥2.98B27.022.56%-3.06%-38.56%
68
Neutral
¥93.51B16.022.47%1.86%1370.48%
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
62
Neutral
¥43.16B10.690.91%15.77%-50.57%
60
Neutral
¥5.75B23.204.07%6.08%38.00%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:194A
WOLVES HAND Co.,Ltd.
1,678.00
932.00
124.93%
JP:2373
Care Twentyone Corporation
427.00
29.02
7.29%
JP:2425
Care Service Co., Ltd.
785.00
-69.14
-8.09%
JP:6197
Solasto Corp.
987.00
532.07
116.96%
JP:7071
Amvis Holdings.Inc.
439.00
-71.62
-14.03%
JP:9220
FB CARE SERVICE CO.,LTD.
1,196.00
259.40
27.70%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Nov 28, 2025